GenEdit Announces Multiyear Collaboration and License Agreement with Genentech to Develop Novel Nanoparticles to Deliver Genetic Medicines for Autoimmune Disease

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #CRISPR–GenEdit Announces Multiyear Collaboration and License Agreement with Genentech
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks